Nichi Asia Life Sciences

Nichi-Asia Life Sciences is a Malaysian biotechnology company focused on regenerative medicine and advanced cell-based therapies. Established as a collaboration with Japanese partners, the company specializes in Autologous Immune Enhancement Therapy (AIET), which utilizes Natural Killer (NK) cells and Activated T-Lymphocytes to treat various forms of cancer. Beyond oncology, Nichi-Asia provides stem cell processing and banking services for applications in orthopedics and degenerative disorders. The company leverages proprietary Japanese technologies, such as thermoreversible hydrogels, to enhance cell culture and clinical outcomes. Nichi-Asia operates specialized laboratory facilities in Malaysia that adhere to international standards for cell processing and quality control. Their mission is to bridge the gap between laboratory research and clinical application in the field of regenerative medicine across Southeast Asia.